Co-Authors
This is a "connection" page, showing publications co-authored by Cataldo Patruno and Stefano Dastoli.
Connection Strength
0.703
-
Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19. Dermatol Ther. 2021 11; 34(6):e15111.
Score: 0.241
-
Erythema Multiforme and COVID-19: What Do We Know? Medicina (Kaunas). 2021 Aug 16; 57(8).
Score: 0.241
-
Are erythema multiforme and urticaria related to a better outcome of COVID-19? Dermatol Ther. 2020 Jul; 33(4):e13681.
Score: 0.222